Cancer Biomarker Reporting Committee



To develop and maintain structured pathology reporting templates and related educational materials for cancer biomarker testing to aid in the diagnosis, treatment, and prognosis of cancer patients.

This committee reports to the Council on Scientific Affairs and ancillary to the Cancer Committee. View a list of the current committee members and find additional resources and information in the reporting templates for cancer biomarkers.


Time Commitment Requirements
Number of face-to-face meetings 2
Length of meetings 1 day
Typical meeting days Saturday
Meeting locations Meetings are typically held at a location less than 50 miles from an airport. One meeting per year is held in Chicago.
Number of conference calls Scheduled as needed; 1 to 1.5 hours each
Hours/year of committee work required outside of meetings Members 40-60, Vice-Chair 40-60, Chair 80+
Additional travel or time commitments Attendance at Council on Scientific Affairs Leadership and cancer committee meetings for chair, as needed.

Activities of Committee

  • Develop the cancer biomarker reporting templates, mirroring the format and content guidelines of the CAP Cancer protocols as closely as possible.
  • Act as "advisors" to the CAP regarding issues related to cancer biomarker reporting.
  • Monitor new and emerging guidelines and expert consensus to create standardized biomarker reporting templates.
  • Facilitate communication and collaboration between the end-user pathologists; the CAP Cancer Committee; and other CAP committees, such as pathology electronic reporting (PERT), molecular oncology, immunohistochemistry, and cytopathology as well as outside organization stakeholders.
  • Collaborate with the PERT Committee and the CAP electronic Cancer Checklists (eCC) staff to help produce electronic versions of the cancer biomarker reporting committee templates, following the same management and workflow that is currently in place for converting the CAP cancer protocols to eCC format.

Expertise or Experience

  • Interest in promoting pathology as leaders in cancer biomarker reporting.
  • Commitment to advancing excellence in cancer reporting and/or cancer biomarker standards.

Benefits of Committee Membership

  • Opportunity to meet and work with pathologists and clinicians from a variety of practice settings and organizations
  • Opportunity to publish materials
  • Opportunity to speak at educational events
  • Opportunity to participate in developing recommendations for the practice of pathology

Representation on Committee Beyond the CAP

The cancer biomarker reporting committee has inbound liaisons from the following organizations:

  • American College of Surgeons - National Cancer Data Base (ACoS-NCDB)
  • American Joint Committee on Cancer (AJCC)
  • American Society of Clinical Oncology (ASCO)
  • Association for Molecular Pathology (AMP)
  • Centers for Disease Control and Prevention - National Program of Cancer Registries (CDC-NPCR)
  • HL7 Clinical Genomics Work Group (HL7-CGWG)
  • National Comprehensive Cancer Network (NCCN)
  • North American Association of Central Cancer Registries (NAACCR)

Interested in Joining this Committee?